Related references
Note: Only part of the references are listed.Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Tahmineh Kandelouei et al.
MEDIATORS OF INFLAMMATION (2022)
Coronary In-Stent Restenosis: Predictors and Treatment
Helen Ullrich et al.
DEUTSCHES ARZTEBLATT INTERNATIONAL (2022)
Investigation Into the Risk Factors Related to In-stent Restenosis in Elderly Patients With Coronary Heart Disease and Type 2 Diabetes Within 2 Years After the First Drug-Eluting Stent Implantation
Ming Yi et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Comparison of high-sensitivity C-reactive protein vs. C-reactive protein for diagnostic accuracy and prediction of mortality in patients with acute myocardial infarction
Felix Hofer et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2021)
Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis
MengYing Zeng et al.
BMC CARDIOVASCULAR DISORDERS (2021)
Long-Term Outcomes Following Drug-Eluting Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis (DEB-Dragon-Registry)
Wojciech Wanha et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2021)
High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a) Multi-Ethnic Study of Atherosclerosis
Wei Zhang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Inflammation and Stroke Risk: A New Target for Prevention
Peter J. Kelly et al.
STROKE (2021)
Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis
Daisuke Nakamura et al.
EUROINTERVENTION (2021)
Roles of MicroRNAs in Peripheral Artery In-Stent Restenosis after Endovascular Treatment
Mo Wang et al.
BIOMED RESEARCH INTERNATIONAL (2021)
Effect of Heart Failure on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Severe Coronary Artery Disease
Ko Yamamoto et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, placebo-controlled clinical trial
Arash Gholoobi et al.
INFLAMMOPHARMACOLOGY (2021)
Hypercholesterolemia Aggravates In-stent Restenosis In Rabbits By Escalating Vascular Inflammation
Vaishali Inamdar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Rapamycin-eluting Single and Double Stenting on Serum Markers in Coronary Bifurcation Lesions
Jintao Wang et al.
JCPSP-Journal of the College of Physicians and Surgeons Pakistan (2020)
Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial
Wei Yao et al.
MEDICAL SCIENCE MONITOR (2020)
The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do
Pengfei Wang et al.
BMC CARDIOVASCULAR DISORDERS (2020)
Predictors of In-Stent Restenosis
Mehmet Kadri Akboga et al.
ANGIOLOGY (2019)
Restenosis of Drug-Eluting Stents A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review
Evan Shlofmitz et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2019)
The long-term prognostic significance of high-sensitive C-reactive protein to in-stent restenosis
Xinyi Zhu et al.
MEDICINE (2018)
Clinical Outcomes of Drug-Eluting Balloon for In-Stent Restenosis Based on the Number of Metallic Layers The New Tokyo Registry
Hiroto Yabushita et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2018)
The Use of High Sensitivity C-Reactive Protein in Cardiovascular Disease Detection
Ana Rita Castro et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2018)
Inflammation and In-Stent Restenosis
Koray Demirtas
ANGIOLOGY (2018)
Clinical outcomes in patients treated for coronary in-stent restenosis with drug-eluting balloons: Impact of high platelet reactivity
Adrienn Tornyos et al.
PLOS ONE (2017)
From C-Reactive Protein to Interleukin-6 to Interleukin-1 Moving Upstream To Identify Novel Targets for Atheroprotection
Paul M. Ridker
CIRCULATION RESEARCH (2016)
Impact of statin non-adherence on in-stent restenosis following bare-metal stent implantation
Cuneyt Kocas et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome
Juan Gaztanaga et al.
ATHEROSCLEROSIS (2015)
High-Sensitivity C-Reactive Protein as a Predictor of Cardiovascular Events after ST-Elevation Myocardial Infarction
Daniel Rios Pinto Ribeiro et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2014)
Clinical Presentation and Outcomes of Coronary In-Stent Restenosis Across 3-Stent Generations
Marco A. Magalhaes et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2014)
Do Statins have a Role in Reduction/Prevention of Post-PCI Restenosis?
Kailash Prasad
CARDIOVASCULAR THERAPEUTICS (2013)
First-in-Man Study of Simvastatin-Eluting Stent in De Novo Coronary Lesions - The SIMVASTENT Study
Alexandre C. Zago et al.
CIRCULATION JOURNAL (2012)
A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis
Alexandra Vodolazkaia et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2011)
Effect of oral sirolimus therapy on inflammatory biomarkers following coronary stenting
W. C. M. Rosa et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2010)
Reduced systemic inflammatory response to implantation of sirolimus-eluting stents in patients with stable coronary artery disease
George E. Kochiadakis et al.
ATHEROSCLEROSIS (2007)
Coronary stenting and inflammation
A Gaspardone et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Serum concentrations of high-sensitivity C-reactive protein predict progressively obstructive lesions rather than late restenosis in patients with unstable angina undergoing coronary artery stenting
HK Yip et al.
CIRCULATION JOURNAL (2005)
Serial changes in circulating concentrations of soluble CD40 ligand and C-reactive protein in patients with unstable angina undergoing coronary stenting - Role of inflammatory mediators in predicting late restenosis
HK Yip et al.
CIRCULATION JOURNAL (2005)
Does a carbon ion-implanted surface reduce the restenosis rate of coronary stents? Comparison of in-stent restenosis and inflammatory reaction of a carbon ion-implanted stent versus a standard unimplanted stent
JH Jung et al.
CARDIOLOGY (2005)
Effects of atorvastatin on in-stent stenosis in normo- and hypercholesterolemic rabbits
C Herdeg et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2003)
Share Paper
